Telmisartan/ Rosuvastatin 80/20 mg

Adult dose

Telmisartan: For essential hypertension, it is recommended to administer 40 mg orally once daily, and depending on the patient, 20 mg once daily may also be effective. If needed, the dosage can be increased up to 80 mg once daily. For the purpose of reducing cardiovascular disease risk, it is recommended to administer 80 mg orally once daily. In patients with liver impairment, care must be taken not to exceed 40 mg once daily. Rosuvastatin Calcium: Primary

This drug can cause serious harm to the fetus and newborn if taken during pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. It is not to be administered to individuals allergic to this drug, pregnant or breastfeeding women, and fertile women not using appropriate contraception. It is safe not to use in patients with severe liver damage or those with bile flow problems. In patients with severe renal impairment or when combined with certain medications, this drug should not be used. Elderly patients or those with elevated blood potassium levels, or those with slightly impaired liver function must use this drug cautiously, requiring regular blood tests and monitoring of health status. This drug may lead to muscle-related side effects such as myalgia or muscle weakness, so any unusual symptoms should be reported to a physician immediately. If symptoms such as severe myalgia, muscle weakness, muscle cramps occur, or if blood tests show significantly elevated muscle damage markers, the medication should be discontinued. Since liver function abnormalities may occur, regular liver function tests should be conducted while taking this drug. Be aware that this drug may interact with other medications; inform your physician or pharmacist of any other medications being taken. Due to its potent hypotensive effect, be cautious of symptoms such as low blood pressure, dizziness, and fainting. Avoid alcohol consumption while taking this drug, especially if there is a history of liver disease. Women of childbearing potential must use proper contraception while taking this drug, and must discontinue immediately upon confirmation of pregnancy. Breastfeeding women are advised not to take this drug; if it must be taken, breastfeeding should be stopped. This drug's safety and efficacy have not been established in children, so its use is generally not recommended. In case of overdose, symptoms such as low blood pressure, dizziness, and acute renal failure may occur, requiring immediate medical attention. During treatment with this drug, be cautious while driving or operating dangerous machinery, as dizziness or drowsiness may occur. Store in a place out of reach of children and do not transfer to another container.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, peeling skin, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attack, cough + fever accompanied respiratory abnormalities, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizure, confusion, visual disturbances, paralysis, urinary changes

Mild side effects

• Headache
• postural dizziness
• sleepiness
• hypertension or hypotension
• low blood pressure
• ALT elevation
• painful urination
• rhinitis
• pharyngodynia
• pulmonary disease

This medicine should be stored in a sealed container to prevent exposure to air or moisture, and it should be kept at a temperature between 1°C and 30°C. Therefore, it is important to store it in a cool, dry place until use.

Appearance

White oval film-coated tablets

Package unit

30 tablets/box [10 tablets/PTP*3]